Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -429.55x is 49% above its 5-year average of -841.64x, near the high end of its 5-year range (-2663.56x–-229.95x).
23.27% above its 12-month average of -559.80x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -907.86x.
INTEREST COVERAGE RATIO
-429.55x
INTEREST COVERAGE RATIO AVG TTM
-559.80x
INTEREST COVERAGE RATIO AVG 3Y
-1235.56x
INTEREST COVERAGE RATIO AVG 5Y
-841.64x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+23.27%
CURRENT VS 3Y AVG
+65.23%
CURRENT VS 5Y AVG
+48.96%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
-7318.83%
vs the sector median at left
Personalis, Inc.
Market Cap
$1.70B
Interest Coverage Ratio
-429.55x
TTM Avg
-559.80x
3Y Avg
-1235.56x
5Y Avg
-841.64x
Market Cap
$1.70B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.72B
Interest Coverage Ratio
2.86x
TTM Avg
2.86x
3Y Avg
2.86x
5Y Avg
6.42x
Market Cap
$1.76B
Interest Coverage Ratio
0.86x
TTM Avg
0.86x
3Y Avg
0.86x
5Y Avg
0.86x
Market Cap
$1.75B
Interest Coverage Ratio
1.43x
TTM Avg
1.58x
3Y Avg
1.58x
5Y Avg
1.43x
Market Cap
$1.65B
Interest Coverage Ratio
-3.88x
TTM Avg
0.61x
3Y Avg
0.61x
5Y Avg
0.61x
Market Cap
$1.78B
Interest Coverage Ratio
0.93x
TTM Avg
0.93x
3Y Avg
0.93x
5Y Avg
0.93x
Market Cap
$1.62B
Interest Coverage Ratio
4.05x
TTM Avg
2.04x
3Y Avg
1.94x
5Y Avg
1.94x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Personalis, Inc. (PSNL) | $1.70B | -429.55x | -559.80x | -1235.56x | -841.64x |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.70B | N/A | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.72B | 2.86x | 2.86x | 2.86x | 6.42x |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.76B | 0.86x | 0.86x | 0.86x | 0.86x |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 1.43x | 1.58x | 1.58x | 1.43x |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | -3.88x | 0.61x | 0.61x | 0.61x |
| Septerna Inc (SEPN)vs › | $1.65B | N/A | N/A | N/A | N/A |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.78B | 0.93x | 0.93x | 0.93x | 0.93x |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.62B | 4.05x | 2.04x | 1.94x | 1.94x |
| Absci Corporation (ABSI)vs › | $1.79B | -596.74x | N/A | N/A | N/A |
Interest Coverage
-429.6x
Debt/Equity
0.16
Current Ratio
5.28
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -907.86x |
| 2026-03-31 | -684.28x |
| 2025-12-31 | -388.71x |
| 2025-09-30 | -363.92x |
| 2025-06-30 | -454.25x |
| 2025-03-31 | -632.00x |
| 2024-09-30 | -2054.57x |
| 2024-06-30 | -1877.00x |
| 2024-03-31 | -2097.78x |
| 2023-12-31 | -2663.56x |
| 2023-09-30 | -2052.87x |
| 2023-06-30 | -649.90x |
| 2023-03-31 | -634.57x |
| 2022-12-31 | -682.66x |
| 2022-09-30 | -605.76x |
| 2022-06-30 | -557.62x |
| 2022-03-31 | -479.76x |
| 2021-12-31 | -342.80x |
| 2021-09-30 | -294.85x |
| 2021-06-30 | -229.95x |
| 2020-03-31 | -4812.50x |
| 2019-09-30 | -28.09x |
| 2019-06-30 | -5.45x |
| 2019-03-31 | -29.52x |
| 2018-12-31 | -12.90x |
| 2018-09-30 | -3.85x |
| 2018-06-30 | -6.47x |
| 2018-03-31 | -8.30x |
